175 related articles for article (PubMed ID: 38001668)
1. Oleic Acid Exhibits Anti-Proliferative and Anti-Invasive Activities via the PTEN/AKT/mTOR Pathway in Endometrial Cancer.
Deng B; Kong W; Suo H; Shen X; Newton MA; Burkett WC; Zhao Z; John C; Sun W; Zhang X; Fan Y; Hao T; Zhou C; Bae-Jump VL
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001668
[TBL] [Abstract][Full Text] [Related]
2. Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer.
Qiu J; Zhao Z; Suo H; Paraghamian SE; Hawkins GM; Sun W; Zhang X; Hao T; Deng B; Shen X; Zhou C; Bae-Jump V
Cancer Biol Ther; 2024 Dec; 25(1):2325130. PubMed ID: 38465855
[TBL] [Abstract][Full Text] [Related]
3. Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.
Pierce SR; Fang Z; Yin Y; West L; Asher M; Hao T; Zhang X; Tucker K; Staley A; Fan Y; Sun W; Moore DT; Xu C; Tsai YH; Parker J; Prabhu VV; Allen JE; Lee D; Zhou C; Bae-Jump V
J Exp Clin Cancer Res; 2021 Feb; 40(1):61. PubMed ID: 33557912
[TBL] [Abstract][Full Text] [Related]
4. The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and
Roque DR; Zhang L; Wysham WZ; Han J; Sun W; Yin Y; Livingston JN; Batchelor KW; Zhou C; Bae-Jump VL
Front Oncol; 2021; 11():690435. PubMed ID: 34422646
[TBL] [Abstract][Full Text] [Related]
5. Reversal of obesity-driven aggressiveness of endometrial cancer by metformin.
Guo H; Kong W; Zhang L; Han J; Clark LH; Yin Y; Fang Z; Sun W; Wang J; Gilliam TP; Lee D; Makowski L; Zhou C; Bae-Jump VL
Am J Cancer Res; 2019; 9(10):2170-2193. PubMed ID: 31720081
[TBL] [Abstract][Full Text] [Related]
6. Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer
O'Donnell J; Zhao Z; Buckingham L; Hao T; Suo H; Zhang X; Fan Y; John C; Deng B; Shen X; Sun W; Secord AA; Zhou C; Bae-Jump VL
Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37503790
[TBL] [Abstract][Full Text] [Related]
7. Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer.
Staley A; Tucker K; Yin Y; Zhang X; Fan Y; Zhang Y; Fang Z; Sun W; Suo H; Zhao X; Zhao Z; Prabhu VV; Allen JE; Zhou C; Bae-Jump VL
Am J Cancer Res; 2021; 11(11):5374-5387. PubMed ID: 34873466
[TBL] [Abstract][Full Text] [Related]
8. A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibition.
Cheng H; Liu P; Zhang F; Xu E; Symonds L; Ohlson CE; Bronson RT; Maira SM; Di Tomaso E; Li J; Myers AP; Cantley LC; Mills GB; Zhao JJ
Cancer Res; 2014 Jan; 74(1):15-23. PubMed ID: 24322983
[TBL] [Abstract][Full Text] [Related]
9. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308
[TBL] [Abstract][Full Text] [Related]
10. SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse models.
Zhao X; Kong W; Tucker K; Staley A; Fan Y; Sun W; Yin Y; Huang Y; Fang Z; Wang J; Sen S; Dugar S; Zhou C; Bae-Jump VL
Am J Transl Res; 2020; 12(8):4264-4276. PubMed ID: 32913503
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer.
Schointuch MN; Gilliam TP; Stine JE; Han X; Zhou C; Gehrig PA; Kim K; Bae-Jump VL
Gynecol Oncol; 2014 Aug; 134(2):346-55. PubMed ID: 24880141
[TBL] [Abstract][Full Text] [Related]
12. The Glutaminase Inhibitor Compound 968 Exhibits Potent
Guo H; Li W; Pan G; Wang C; Li D; Liu N; Sheng X; Yuan L
Anticancer Agents Med Chem; 2023; 23(2):210-221. PubMed ID: 35570522
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of human endometrial carcinoma cells with different PTEN expression to mitogen-activated protein kinase signaling inhibits and implications for therapy.
Xiao L; Yang YB; Li XM; Xu CF; Li T; Wang XY
J Cancer Res Clin Oncol; 2010 Jul; 136(7):1089-99. PubMed ID: 20087603
[TBL] [Abstract][Full Text] [Related]
14. Palmitic Acid Exerts Anti-Tumorigenic Activities by Modulating Cellular Stress and Lipid Droplet Formation in Endometrial Cancer.
Zhao Z; Wang J; Kong W; Newton MA; Burkett WC; Sun W; Buckingham L; O'Donnell J; Suo H; Deng B; Shen X; Zhang X; Hao T; Zhou C; Bae-Jump VL
Biomolecules; 2024 May; 14(5):. PubMed ID: 38786008
[TBL] [Abstract][Full Text] [Related]
15. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
16. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN.
Deng W; Han W; Fan T; Wang X; Cheng Z; Wan B; Chen J
Biomed Pharmacother; 2018 Nov; 107():1505-1513. PubMed ID: 30257368
[TBL] [Abstract][Full Text] [Related]
17. The Role of Specificity Protein 1 (SP1) in Bladder Cancer Progression through PTEN-Mediated AKT/mTOR Pathway.
Chen Z
Urol Int; 2023; 107(9):848-856. PubMed ID: 37666229
[TBL] [Abstract][Full Text] [Related]
18. Orlistat exerts anti-obesity and anti-tumorigenic effects in a transgenic mouse model of endometrial cancer.
Xu G; Zhao Z; Wysham WZ; Roque DR; Fang Z; Sun W; Yin Y; Deng B; Shen X; Zhou C; Bae-Jump V
Front Oncol; 2023; 13():1219923. PubMed ID: 37601677
[TBL] [Abstract][Full Text] [Related]
19. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
20. Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 Positive Feedback Loop Induces Cell Cycle Arrest by Dual PI3K/mTOR Inhibitor PQR309 in Endometrial Cancer Cell Lines.
Hsin IL; Shen HP; Chang HY; Ko JL; Wang PH
Cells; 2021 Oct; 10(11):. PubMed ID: 34831139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
